Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Appointed director CC transcript
|
INVENTIV HEALTH INC (VTIV)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/09/2016 |
8-K
| Quarterly results |
08/04/2016 |
8-K
| Form 8-K - Current report |
08/03/2016 |
8-K
| Form 8-K - Current report |
05/26/2016 |
8-K
| Form 8-K - Current report |
05/13/2016 |
8-K
| Investor presentation |
05/04/2016 |
8-K
| Form 8-K - Current report |
04/06/2016 |
8-K
| Form 8-K - Current report |
03/30/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
03/22/2016 |
8-K
| Form 8-K - Current report |
03/16/2016 |
8-K
| Form 8-K - Current report |
03/01/2016 |
8-K
| Form 8-K - Current report |
02/12/2016 |
8-K
| Form 8-K - Current report |
01/13/2016 |
8-K
| Investor presentation |
12/02/2015 |
8-K
| Investor presentation |
11/13/2015 |
8-K
| Investor presentation |
10/23/2015 |
8-K
| Other Events |
08/14/2015 |
8-K
| Investor presentation |
08/10/2015 |
8-K
| Other Events |
08/05/2010 |
8-K
| Form 8-K - Current report |
07/27/2010 |
8-K
| Form 8-K - Current report |
07/21/2010 |
8-K
| Form 8-K - Current report |
07/06/2010 |
8-K
| Form 8-K - Current report |
06/09/2010 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/01/2010 |
8-K
| Form 8-K - Current report |
05/27/2010 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
05/11/2010 |
8-K
| Form 8-K - Current report |
05/07/2010 |
8-K
| Form 8-K - Current report |
05/06/2010 |
8-K
| Other Events, Financial Statements and Exhibits
Docs:
|
"inVentiv Health to be Acquired by Thomas H. Lee Partners SOMERSET, N.J., May 6, 2010 — inVentiv Health, Inc. , a leading provider of end-to-end clinical development, launch and commercialization services to the global pharmaceutical and healthcare industries, today announced that it has entered into a definitive agreement to be acquired by Thomas H. Lee Partners, L.P. , a leading private equity firm, for approximately $1.1 billion. Under the terms of the agreement, which has been approved by inVentiv's board of directors, inVentiv shareholders will receive $26.00 in cash for each share of VTIV common stock they hold, representing a 52% premium over the $17.15 closing stock price on March 25, 2010, the day before inVentiv announced that it had been approached by financial investors regardin..." |
|
05/06/2010 |
8-K
| Form 8-K - Current report |
03/19/2010 |
8-K
| Form 8-K - Current report |
02/24/2010 |
8-K
| Form 8-K - Current report |
12/16/2009 |
8-K
| Form 8-K - Current report |
11/05/2009 |
8-K
| Form 8-K - Current report |
08/06/2009 |
8-K
| Form 8-K - Current report |
|
|
|